RNA-based Therapeutics
Is United Therapeutics Corporation (UTHR) The Most Profitable Biotech Stock To Buy Right Now?
The Future of RNA Therapeutics, From Design to Delivery
RNA Biotechs: Current State And Outlook
RNA editing biotech Airna adds $155M in funding
AIRNA nets $155M series B to launch clinical test of RNA editing tech
Flamingo Therapeutics Announces Participation in Upcoming Investor Conferences
Nutcracker Therapeutics CEO Dr. Igor Khandros Retires as Company Continues Evolution as an RNA Therapeutics CRDMO
AIRNA secures $155m to bring RNA-candidate to clinic
RNA Nanotechnology
Nature-inspired nanotechnology acts as body's own courier service for genetic medicines
RNA origami: Artificial cytoskeletons to build synthetic cells
RNA origami technique folds nanotubes to create artificial cytoskeletons for synthetic cells
Tiny exosome couriers rewrite the healing code — RNA delivery sparks a new era in ischemic disease treatment
News on nanotechnology
New method uses DNA barcodes for high throughput RNA and protein detection in deep tissue
Magnetic Tweezers: A Powerful Tool for Manipulating Biomolecules at the Nanoscale
RNA origami: Artificial cytoskeletons to build synthetic cells (w/video)
RNA Vaccines
Q&A: Nobel Prize-winning researcher and BU grad discusses vaccine development, vaccine hesitancy, and preparing for another pandemic
The Future of RNA Therapeutics, From Design to Delivery
Breakthrough mRNA vaccine reinvents pancreatic cancer treatment
TechInvention Taps Belgian Expertise for mRNA Vaccine Revolution
An mRNA cancer vaccine may offer long-term protection
RFK Jr. paused this Peninsula company's half-billion-dollar vaccine contract, then it cut jobs
Emcure Pharma arm Gennova advances development of Nipah virus vaccine
A Wave of State Legislation Is Targeting mRNA Vaccines for Livestock
mRNA, saRNA Vaccine Production Boost in India - TechInvention & Quantoom Partnership
RNA
The battle between resilient plants and cunning viruses: Study discovers a novel RNA silencing mechanism
AIRNA secures $155m to bring RNA-candidate to clinic
Exploring exosomal RNA as a biomarker for prostate cancer detection
AIRNA nets $155M series B to launch clinical test of RNA editing tech
RNA editing biotech Airna adds $155M in funding
RNA interference and nanomedicine join forces to fight dangerous fungal infections
AIRNA Hits $155M Series B Haul To Advance RNA Editor for Rare Genetic Disease
RNA Biotechs: Current State And Outlook
A bioluminescent probe to track RNA
Aqemia Advances Epitranscriptomics Programs and Expands into Small-Molecule RNA Targeting with $7.4 Million Grant
